CPT code 83020 covers hemoglobin fractionation performed by electrophoresis, a laboratory procedure that identifies and quantifies hemoglobin variants. This test is clinically important for diagnosing and monitoring hemoglobinopathies such as sickle cell disease and thalassemia, and it supports treatment decisions and genetic counseling. Nationally, hemoglobin electrophoresis remains a core diagnostic tool in hematology and newborn follow-up programs.

Key payers covered in this overview include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise explanation of what the code represents, typical sites of service, and the clinical context for ordering the test. The publication also outlines benchmarks where available, common billing and coverage considerations, and recent policy updates that affect laboratory coding and reimbursement practices.

This analysis provides payers' coverage perspective and coding context so clinical laboratories and billing professionals can align documentation and claims submission with payer expectations. Data not available in the input is noted where applicable.